Abiopharma

Tiziana Life Sciences Announces Purchase of Shares by Chairman

New Form 424B4 - PURPLE BIOTECH LTD. Filed: 2025-09-05 AccNo: 0001213900-25-084733 Size: 396 KB

New Form 6-K - Tiziana Life Sciences Ltd Filed: 2025-09-05 AccNo: 0001213900-25-084732 Size: 30 KB

Press Release: DiaMedica Therapeutics to Participate in Upcoming Investor Conferences

Safety Shot Appoints BONK Core Contributor Mitchell Rudy (Nom) to Board of Directors

New Form 6-K - NuCana plc Filed: 2025-09-05 AccNo: 0001193125-25-196589 Size: 21 KB

Bausch Health Notification

Avadel Pharmaceuticals to Present New Data onLUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NuCana Compliant with All Nasdaq Continued Listing Criteria

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 425 - Monogram Technologies Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087632 Size: 31 KB

New Form 8-K - Monogram Technologies Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087631 Size: 208 KB Item 8.01: Other Events